Filter by
JRC news and updates (1)
RSSShowing results 1 to 1
News type
JRC portfolios
Novel therapy used in an ongoing Phase I clinical study shows substantial antitumour effect in patients with metastatic castration-resistant prostate cancer (mCRPC).